Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
22.19
+0.31 (1.42%)
At close: Oct 15, 2026, 4:00 PM EDT
22.40
+0.21 (0.95%)
After-hours: Oct 15, 2026, 7:49 PM EDT
Structure Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $111 | Buy | Maintains | $111 | +400.23% | Sep 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $70 | Buy | Reiterates | $70 | +215.46% | Sep 9, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $104 | Buy | Maintains | $104 | +368.68% | Sep 8, 2026 |
| Jefferies | Jefferies | Buy Maintains $125 | Buy | Maintains | $125 | +463.32% | Sep 8, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 8, 2026 |
| Clear Street | Clear Street | Buy Maintains $99 | Buy | Maintains | $99 | +346.15% | Sep 8, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $100 | Buy | Maintains | $100 | +350.65% | Aug 17, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $126 | Buy | Reiterates | $126 | +467.82% | Aug 10, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.